See https://www.magonlinelibrary.com/doi/pdf/10.12968/jowc.2021.30.2.96Objective: To demonstrate the efficacy of the SafeZone UVC (UshioInc., Japan) 222nm ultraviolet C (UVC) light to reduce bacterialburden in pressure ulcers (PUs) in human patients. This research isthe first human clinical trial using 222nm UVC in eradicating bacteriain human wounds.Method: Patients with Stage 2 or 3 (as defined by the revised NationalPressure Ulcer…
This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
